These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer. Yang SNY; Atkinson SC; Wang C; Lee A; Bogoyevitch MA; Borg NA; Jans DA Antiviral Res; 2020 May; 177():104760. PubMed ID: 32135219 [TBL] [Abstract][Full Text] [Related]
29. Zika virus infects pericytes in the choroid plexus and enters the central nervous system through the blood-cerebrospinal fluid barrier. Kim J; Alejandro B; Hetman M; Hattab EM; Joiner J; Schroten H; Ishikawa H; Chung DH PLoS Pathog; 2020 May; 16(5):e1008204. PubMed ID: 32357162 [TBL] [Abstract][Full Text] [Related]
31. Antimalarial drugs and their metabolites are potent Zika virus inhibitors. Han Y; Pham HT; Xu H; Quan Y; Mesplède T J Med Virol; 2019 Jul; 91(7):1182-1190. PubMed ID: 30801742 [TBL] [Abstract][Full Text] [Related]
32. The Polyphenol-Rich Extract from Clain E; Haddad JG; Koishi AC; Sinigaglia L; Rachidi W; Desprès P; Duarte Dos Santos CN; Guiraud P; Jouvenet N; El Kalamouni C Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991717 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model. Julander JG; Siddharthan V; Evans J; Taylor R; Tolbert K; Apuli C; Stewart J; Collins P; Gebre M; Neilson S; Van Wettere A; Lee YM; Sheridan WP; Morrey JD; Babu YS Antiviral Res; 2017 Jan; 137():14-22. PubMed ID: 27838352 [TBL] [Abstract][Full Text] [Related]
34. Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus. Surnar B; Kamran MZ; Shah AS; Basu U; Kolishetti N; Deo S; Jayaweera DT; Daunert S; Dhar S ACS Nano; 2019 Oct; 13(10):11034-11048. PubMed ID: 31603314 [TBL] [Abstract][Full Text] [Related]
35. Anti-Zika virus activity and chemical characterization by ultra-high performance liquid chromatography (UPLC-DAD-UV-MS) of ethanol extracts in Tecoma species. Reis ACC; Silva BM; de Moura HMM; Pereira GR; Brandão GC BMC Complement Med Ther; 2020 Aug; 20(1):246. PubMed ID: 32767975 [TBL] [Abstract][Full Text] [Related]
36. An Alanine-to-Valine Substitution in the Residue 175 of Zika Virus NS2A Protein Affects Viral RNA Synthesis and Attenuates the Virus In Vivo. Márquez-Jurado S; Nogales A; Ávila-Pérez G; Iborra FJ; Martínez-Sobrido L; Almazán F Viruses; 2018 Oct; 10(10):. PubMed ID: 30301244 [TBL] [Abstract][Full Text] [Related]
38. Polysulfonate suramin inhibits Zika virus infection. Tan CW; Sam IC; Chong WL; Lee VS; Chan YF Antiviral Res; 2017 Jul; 143():186-194. PubMed ID: 28457855 [TBL] [Abstract][Full Text] [Related]
39. Drugs for the Treatment of Zika Virus Infection. Bernatchez JA; Tran LT; Li J; Luan Y; Siqueira-Neto JL; Li R J Med Chem; 2020 Jan; 63(2):470-489. PubMed ID: 31549836 [TBL] [Abstract][Full Text] [Related]
40. Antiviral CD8 T cells induce Zika-virus-associated paralysis in mice. Jurado KA; Yockey LJ; Wong PW; Lee S; Huttner AJ; Iwasaki A Nat Microbiol; 2018 Feb; 3(2):141-147. PubMed ID: 29158604 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]